Baseline D-dimers as predictive marker of efficacy of cemiplimab treatment in cutaneous squamous cell carcinoma.

Saved in:
Bibliographic Details
Title: Baseline D-dimers as predictive marker of efficacy of cemiplimab treatment in cutaneous squamous cell carcinoma.
Authors: Geidel G; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Adam L; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Bänsch S; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Fekade N; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Degenhardt S; Department of Dermatology, Elbe Kliniken Buxtehude, Buxtehude, Germany., Rünger A; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Kött J; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Zell T; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Heidrich I; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Smit DJ; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Greinert R; Department of Dermatology, Elbe Kliniken Buxtehude, Buxtehude, Germany., Volkmer B; Department of Dermatology, Elbe Kliniken Buxtehude, Buxtehude, Germany., Pantel K; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Mohr P; Department of Dermatology, Elbe Kliniken Buxtehude, Buxtehude, Germany., Hauschild A; Department of Dermatology, University Medical Center Schleswig-Holstein (UKSH), Kiel, Germany., Schneider SW; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: st.schneider@uke.de., Gebhardt C; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: ch.gebhardt@uke.de.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2025 Aug 26; Vol. 226, pp. 115639. Date of Electronic Publication: 2025 Jul 10.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0852
DOI:10.1016/j.ejca.2025.115639